News
One in five men is affected by prostate cancer
At Vitus Prostate Center we always keep our finger on the pulse of the latest developments, thanks to the close co-operation of our medical doctors…
Read More
Participation in Multi-Center Register Study for IRE
Medical doctors and scientists at the Vitus Prostate Center in Frankfurt/Offenbach have been using Irreversible Electroporation (IRE; product name: NanoKnife®) for the treatment of prostate…
Read More
Irreversible electroporation: Where We Stand and Where We Go
Irreversible electroporation (IRE) is the latest in the series of image-guided locoregional tumor ablation therapies. IRE is performed in a nearly nonthermal fashion that circumvents…
Read More
Treatment of Prostate Cancer with Irreversible Electroporation (IRE)
Irreversible Electroporation (IRE), over the last few years, has established itself as a novel method in the field of focal cancer ablation in many medical…
Read More
Global Congress on Prostate Cancer 2016
The medical and scientific team of Prof. Stehling, the world’s leading expert in the irreversible electroporation of prostate carcinomas, presented the current data and facts…
Read More
The Prostata Center is invited to speak at the Radiological Society of North America (RSNA)
The RSNA is a nonprofit medical society with an international membership. Prof. Stehling and his scientific team present both up-to-date numbers on IRE in the…
Read More
Prostate Cancer Treatment with Irreversible Electroporation
This document is based on the presentation which was given on the World Congress On Electroporation and Pulsed Electric Fields in Biology, Medicine, and Food…
Read More
Global Congress on Prostate Cancer 2015 in Rome
Prof. Stehling and his scientific team presented current data on IRE for the treatment of prostate cancer at the Global Congress on Prostate Cancer. Read…
Read More
Our numbers presented at the SIR 2015 Annual Scientific Meeting
Our data was presented at the SIR Annual Scientific Meeting. Read our abstract with the titel “Irreversible electroporation treatment for prostate adenocarcinomas: a safety outcome…
Read More